Li-Heng Pao

Title: Innovations and Contributions of Li-Heng Pao

Introduction

Li-Heng Pao is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of medications targeting influenza and enhancing drug efficacy.

Latest Patents

Li-Heng Pao holds 4 patents that showcase his innovative work. His latest patents include the use of mycophenolate mofetil or its pharmaceutically acceptable salts in preparing drugs to combat influenza virus. This invention not only addresses the influenza virus but also targets drug-resistant strains. Additionally, he has developed inhibitors and enhancers of uridine diphosphate-glucuronosyltransferase 2B (UGT2B), which can increase the bioavailability of drugs and enhance the clearance rate of morphine-like analgesic agents.

Career Highlights

Throughout his career, Li-Heng Pao has worked with esteemed organizations such as the National Defense Medical Center and Giant Force Technology Corporation. His work in these institutions has allowed him to contribute to significant advancements in medical research and drug development.

Collaborations

Li-Heng Pao has collaborated with various professionals in his field, including Cheng-Huei Hsiong and Yoa-Pu Hu Oliver, who have supported his innovative endeavors.

Conclusion

Li-Heng Pao's contributions to pharmaceutical innovations demonstrate his commitment to advancing medical science. His patents reflect a deep understanding of drug development and a dedication to improving health outcomes.